- As the delta variant created unexpected disruptions in many of markets, Nu Skin Enterprises (NYSE:NUS) now expects Q3 revenue between $637M and $642M much below vs. prior guidance of $700M to $730M and consensus of $721.8M.
- Unanticipated government restrictions also impacted company's ability to sell and distribute products, with the largest impact in Mainland China and Southeast Asia.
- "Despite the unanticipated COVID-related disruptions, our Collagen+ launch in the U.S. drove continued strong growth, and we successfully introduced our Tencent digital tools in China during the quarter. We are optimistic about our upcoming product launches and the rollout of additional social commerce tools in late 2021 and into next year. We remain confident in our strategy and anticipate annual 2021 revenue to be up modestly year over year."
- Q3 results will be out on November 3, after the market closes.